Heron Therapeutics, Inc. (HRTX): Weighted Average Diluted Shares
Figures left out. The filed Weighted Average Diluted Shares for the year ended 2021-12-31 is not shown: share count out of scale with net income per share. That usually means the filing tagged the figure in the wrong unit.
166.71M
Year ended 2025-12-31
+15.3%
3-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 166.71M | +9.4% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | 152.45M | +10.4% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | 138.13M | +26.9% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | 108.88M | n/a | 2025-02-27, From 2022-01-01 |